Kelly McNagnyView profile
Professor
Dr. Kelly McNagny is a Professor at the University of British Columbia, holding joint appointments in the School of Biomedical Engineering and the Department of Medical Genetics. His career spans immunology, stem cell biology, and biomedical engineering with a focus on inflammatory disease, cancer biology, and regenerative medicine. PhD in Cellular Immunology from University of Alabama at Birmingham Postdoctoral Fellowship at European Molecular Biology Laboratory Co-Director of Biomedical Research Centre Principal Investigator at Centre for Heart Lung Innovation Research focuses on hematopoietic stem cell biology through signaling networks and microenvironment interactions , addressing applications in chronic allergy , asthma , and inflammatory diseases . Recent work explores innate lymphoid cells (ILC2/ILC3), microbiome-driven immunity , and podocalyxin-targeted therapies for pancreatic cancer and ovarian carcinoma . Key article trends include: ILC2/ILC3 roles in intestinal fibrosis and lung inflammation Microbiome analysis linking neonatal microbial exposure to life-long immune skewing Podocalyxin as therapeutic target across solid tumors and kidney disease Computational immunology tools like IQCELL for single-cell trajectory analysis Scientific recognition : Michael Smith Foundation for Health Research Senior Scholar Leadership roles in Stem Cell Network , Immunotherapeutics Cluster , and AllerGen NCE Advisory and Collaborative Efforts : Mentorship of PhD and MSc students (Refaeli, Canals Hernaez, Messing, Shin, Jan-Abu, Yip) Grants from CIHR , NIH , Heart and Stroke Foundation , and NCE Networks Lab team includes Michael Hughes (RA), Julyanne Brassard (PDF), and Kristen Li (Technician)









